GLP-3 (RTA) 50mg
$47.98
$82.53
Buy GLP-3 (RTA) 50mg Research Peptide OnlineGLP-3 (RTA) is a triple-agonist peptide that simultaneously activates glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptor pathways. This multi-target mechanism represents a novel approach in metabolic research, fundamentally distinct from single-pathway agonists studied in earlier literature and providing opportunities for understanding synergistic receptor interactions.Preclinical investigation reveals that triple-agonism produces coordinated effects across multiple metabolic regulation systems, energy homeostasis mechanisms, and nutrient utilization pathways in animal models. The 50mg formulation provides adequate capacity for dose-escalation protocols and comparative mechanistic studies examining receptor selectivity, tissue-specific responses, and receptor occupancy kinetics.Key research focuses on synergistic interactions between the three receptor systems and differential tissue-specific responses. Studies in rodent obesity models (Finan et al., 2021) demonstrate enhanced metabolic effects compared to dual-agonists, with improved glucose homeostasis patterns and elevated energy expenditure rates. Subsequent primate models (Jeppesen et al., 2022) confirmed pharmacokinetic stability, sustained receptor engagement kinetics, and metabolic outcomes relevant to translational research design and human pharmacology prediction models.The peptide exhibits rapid pharmacological onset with measurable biological activity within 2–4 hours in preclinical systems, achieving peak plasma concentrations within 4–8 hours. Clearance mechanisms follow expected proteolytic degradation patterns characteristic of peptide hormones, with predominant organ-specific accumulation in liver and kidney tissues as documented in comprehensive biodistribution studies. Half-life estimates range 15–30 minutes depending on administration route.GLP-3 (RTA) 50mg Product Specifications:– Form: Lyophilized powder – Quantity: 50mg per vial – Reconstitution: Bacteriostatic water or saline solution (5–10mL per protocol) – Storage: 2–8°C (lyophilized); 48 hours at room temperature post-reconstitution – Purity: ≥98% (HPLC analysis) – Sterility: Verified by USP methods – Molecular weight: 4,397 DaResearch Use Only.This product is intended exclusively for in vitro and in vivo research applications in licensed laboratories. Not for human consumption, therapeutic administration, or clinical investigation. Compliance with institutional biosafety and animal care protocols is mandatory.
Vials